# Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study

> **NCT04488601** · PHASE2 · COMPLETED · sponsor: **AgelessRx** · enrollment: 129 (actual)

## Conditions studied

- Aging

## Interventions

- **DRUG:** Rapamycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04488601
- **Lead sponsor:** AgelessRx
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-01-01
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2024-01-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04488601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04488601, "Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT04488601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*